(Q35782813)

10 August 2017

1 reference

title

Mucosal and systemic fungal infections in patients with AIDS: prophylaxis and treatment (English)

1 reference

10 August 2017

1

Markus Ruhnke

1 reference

10 August 2017

language of work or name

1 reference

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

64

1 reference

10 August 2017

issue

11

1 reference

10 August 2017

page(s)

1163-1180

1 reference

Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.

10 August 2017

cites work

1 reference

12 December 2020

Disseminated sporotrichosis in patients with AIDS: case report and review of the literature.

1 reference

12 December 2020

Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature

1 reference

12 December 2020

Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.

1 reference

12 December 2020

Penicillium marneffei Infection in Patients Infected with Human Immunodeficiency Virus

1 reference

12 December 2020

Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.

1 reference

12 December 2020

Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

12 December 2020

A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS

1 reference

12 December 2020

Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy

1 reference

12 December 2020

Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Clinical trial: clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients

1 reference

12 December 2020

In vitro evaluation of voriconazole against some clinically important fungi

1 reference

12 December 2020

Successful treatment of coccidioidal meningitis with voriconazole

1 reference

12 December 2020

Itraconazole cyclodextrin solution--effective treatment for HIV-related candidosis unresponsive to other azole therapy

1 reference

12 December 2020

The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection

1 reference

12 December 2020

The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.

1 reference

12 December 2020

Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.

1 reference

12 December 2020

Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis

1 reference

12 December 2020

Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.

1 reference

12 December 2020

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

1 reference

12 December 2020

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

1 reference

12 December 2020

Paracoccidioidomycosis and AIDS: an overview

1 reference

12 December 2020

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

1 reference

12 December 2020

Oral Candida and Entembacteriaceae in HIV-1 infection: correlation with clinical candidiasis and antimycotic therapy

1 reference

12 December 2020

Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.

1 reference

12 December 2020

Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii

1 reference

12 December 2020

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

1 reference

12 December 2020

Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons

1 reference

12 December 2020

Lipid-based amphotericin B in the treatment of cryptococcosis

1 reference

12 December 2020

Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).

1 reference

12 December 2020

Early mycological treatment failure in AIDS-associated cryptococcal meningitis

1 reference

12 December 2020

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

1 reference

12 December 2020

Blastomycosis in patients with the acquired immunodeficiency syndrome.

1 reference

12 December 2020

Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study

1 reference

12 December 2020

Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America

1 reference

12 December 2020

Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy

1 reference

12 December 2020

From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

1 reference

12 December 2020

Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients

1 reference

12 December 2020

Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy

1 reference

12 December 2020

Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group.

1 reference

12 December 2020

Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection

1 reference

12 December 2020

Aspergillosis in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Refractory mucosal candidiasis in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Pulmonary aspergillosis in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy

1 reference

12 December 2020

Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole

1 reference

12 December 2020

Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis

1 reference

12 December 2020

Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model

1 reference

12 December 2020

Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection

1 reference

12 December 2020

Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patients

1 reference

12 December 2020

In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.

1 reference

12 December 2020

Meningitis caused by Cryptococcus neoformans var. gattii and var. neoformans in Papua New Guinea.

1 reference

12 December 2020

Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America

1 reference

12 December 2020

Disseminated cutaneous sporotrichosis in a patient with AIDS: report of a case.

1 reference

12 December 2020

Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group

1 reference

12 December 2020

Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients

1 reference

12 December 2020

Gynecologic infections in human immunodeficiency virus-infected women

1 reference

12 December 2020

Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial

1 reference

12 December 2020

Disseminated Penicillium marneffei infection associated with human immunodeficiency virus: a report of two cases and a review of 35 published cases

1 reference

12 December 2020

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

12 December 2020

Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions

1 reference

12 December 2020

Mycoses associated with AIDS in the Third World

1 reference

12 December 2020

Disseminated penicilliosis in a patient with acquired immunodeficiency syndrome

1 reference

12 December 2020

Resolution of multidrug-refractory oesophageal candidiasis in an AIDS patient after treatment with caspofungin

1 reference

12 December 2020

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

1 reference

12 December 2020

Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors

1 reference

12 December 2020

Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.

1 reference

12 December 2020

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

1 reference

12 December 2020

Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group

1 reference

12 December 2020

Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America

1 reference

12 December 2020

Guidelines for treatment of candidiasis

1 reference

12 December 2020

Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study

1 reference

12 December 2020

High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS.

1 reference

12 December 2020

A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.

1 reference

12 December 2020

Histoplasmosis in patients with AIDS: efficacy of maintenance amphotericin B therapy

1 reference

12 December 2020

Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group.

1 reference

12 December 2020

Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America

1 reference

12 December 2020

Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994--1998: regional variation and temporal trends

1 reference

12 December 2020

Trichosporon beigelii fungaemia in an AIDS patient

1 reference

12 December 2020

Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and Adolescent Spectrum of HIV Disease Project

1 reference

12 December 2020

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

1 reference

12 December 2020

Endemic mycoses in AIDS: a clinical review

1 reference

12 December 2020

HIV-related oral disease

1 reference

12 December 2020

Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy

1 reference

12 December 2020

Invasive aspergillosis in patients with AIDS.

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

12 December 2020

In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa

1 reference

12 December 2020

Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group

1 reference

12 December 2020

A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand

1 reference

12 December 2020

Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients

1 reference

12 December 2020

Cerebral mucormycosis in two cases of acquired immunodeficiency syndrome

1 reference

12 December 2020

Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases

1 reference

12 December 2020

Coccidioidomycosis among persons with AIDS in the United States

1 reference

12 December 2020

In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum

1 reference

12 December 2020

Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study

1 reference

12 December 2020

Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group

1 reference

12 December 2020

Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir

1 reference

12 December 2020

Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.

1 reference

12 December 2020

Trends in bloodstream infections among human immunodeficiency virus-infected adults admitted to a hospital in Nairobi, Kenya, during the last decade

1 reference

12 December 2020

Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.

1 reference

12 December 2020

Cessation of secondary prophylaxis in patients with cryptococcosis

1 reference

12 December 2020

Hierarchical pattern of mucosal candida infections in HIV-seropositive women

1 reference

12 December 2020

Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.

1 reference

12 December 2020

The immune reconstitution inflammatory syndrome

1 reference

12 December 2020

Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS.

1 reference

12 December 2020

Treatment of oral candidosis with itraconazole: a review

1 reference

12 December 2020

Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases

1 reference

12 December 2020

Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS

1 reference

12 December 2020

A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus

1 reference

12 December 2020

Correlation of fluconazole MICs with clinical outcome in cryptococcal infection

1 reference

12 December 2020

Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group

1 reference

12 December 2020

Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis

1 reference

12 December 2020

Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients

1 reference

12 December 2020

Relapse of coccidioidomycosis despite immune reconstitution after fluconazole secondary prophylaxis in a patient with AIDS.

1 reference

12 December 2020

Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model

1 reference

12 December 2020

A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis

1 reference

12 December 2020

Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS.

1 reference

12 December 2020

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group

1 reference

12 December 2020

Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy

1 reference

12 December 2020

Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients

1 reference

12 December 2020

Candidemia: a nosocomial complication in adults with late-stage AIDS

1 reference

12 December 2020

Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial.

1 reference

12 December 2020

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

1 reference

12 December 2020

Discontinuation of secondary prophylaxis for penicilliosis marneffei in AIDS patients responding to highly active antiretroviral therapy

1 reference

12 December 2020

10.2165/00003495-200464110-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1045799703

0 references

1 reference